Abstract
Objective: Uterine papillary serous carcinoma (UPSC) is an aggressive histologic subtype of endometrial cancer with a poor prognosis. Because of the relative rarity of UPSC, there is still much controversy over optimal adjuvant treatment. We sought to study whether treatment with adjuvant combined chemotherapy and radiation therapy (CT + RT) confers a survival benefit compared to either modality separately in this patient population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
